Cargando…
Editorial: Hereditary Spastic Paraplegias: At the Crossroads of Molecular Pathways and Clinical Options
Autores principales: | Martinuzzi, Andrea, Blackstone, Craig, O'Kane, Cahir J., Stevanin, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258316/ https://www.ncbi.nlm.nih.gov/pubmed/34239414 http://dx.doi.org/10.3389/fnins.2021.708642 |
Ejemplares similares
-
Lipids in the Physiopathology of Hereditary Spastic Paraplegias
por: Darios, Frédéric, et al.
Publicado: (2020) -
Clinical Trial Designs and Measures in Hereditary Spastic Paraplegias
por: Trummer, Brian, et al.
Publicado: (2018) -
Current Knowledge of Endolysosomal and Autophagy Defects in Hereditary Spastic Paraplegia
por: Toupenet Marchesi, Liriopé, et al.
Publicado: (2021) -
Efficacy of a Combined Treatment of Botulinum Toxin and Intensive Physiotherapy in Hereditary Spastic Paraplegia
por: Paparella, Gabriella, et al.
Publicado: (2020) -
Multigeneration family with dominant SPG30 hereditary spastic paraplegia
por: Roda, Ricardo H., et al.
Publicado: (2017)